KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Debt Ratio (2016 - 2020)

Historic Debt Ratio for Neogenomics (NEO) over the last 12 years, with Q1 2020 value amounting to 0.13.

  • Neogenomics' Debt Ratio fell 2581.57% to 0.13 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.13, marking a year-over-year decrease of 2581.57%. This contributed to the annual value of 0.14 for FY2019, which is 2802.18% down from last year.
  • As of Q1 2020, Neogenomics' Debt Ratio stood at 0.13, which was down 2581.57% from 0.14 recorded in Q4 2019.
  • Over the past 5 years, Neogenomics' Debt Ratio peaked at 0.28 during Q2 2018, and registered a low of 0.13 during Q1 2020.
  • Over the past 5 years, Neogenomics' median Debt Ratio value was 0.19 (recorded in 2018), while the average stood at 0.18.
  • As far as peak fluctuations go, Neogenomics' Debt Ratio skyrocketed by 4916.61% in 2017, and later crashed by 4978.27% in 2019.
  • Neogenomics' Debt Ratio (Quarter) stood at 0.22 in 2016, then dropped by 6.64% to 0.2 in 2017, then decreased by 7.19% to 0.19 in 2018, then fell by 28.02% to 0.14 in 2019, then dropped by 4.33% to 0.13 in 2020.
  • Its Debt Ratio stands at 0.13 for Q1 2020, versus 0.14 for Q4 2019 and 0.14 for Q3 2019.